GeoVax prices $3M private placement offering at $1.4799 per unit with warrants

GeoVax Labs, Inc.

Gross proceeds ~$3M; net proceeds ~$2.7M after placement agent fees and expenses.
Issued 2,027,027 pre-funded warrants ($0.0001 exercise) and 4,054,054 common warrants at $1.48 exercise; Series A (5yr), Series B (18mo).
Offering closed May 19, 2026; net proceeds used for working capital and general corporate purposes.
Company agreed to file resale registration statement with SEC for shares underlying the warrants.
A.G.P./Alliance Global Partners acted as sole placement agent; received 7% cash fee plus expense reimbursement.

item 1.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto (effective 2026-05-18).

Action: entry
Agreement: equity purchase
Counterparty: the purchasers party thereto
Effective: 2026-05-18

Exact text from the filing

On May 18, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in an unregistered private placement (the “Offering”), (i) pre-funded warrants

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”) (effective 2026-05-18).

Action: entry
Agreement: underwriting
Counterparty: A.G.P./Alliance Global Partners (the “Placement Agent”)
Effective: 2026-05-18

Exact text from the filing

A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering under a Placement Agency Agreement, dated as of May 18, 2026 (the “Placement Agency Agreement”) between the Company and the Placement Agent.

View on SEC.gov

Browse all material agreements →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-017809

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.